{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:08Z","timestamp":1786114868492,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14811-9","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:03:37Z","timestamp":1780279417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Building resilient and response-ready influenza vaccination programs for pandemic preparedness: a comparative analysis from five middle-income countries"],"prefix":"10.1186","volume":"26","author":[{"given":"Marissa","family":"Malchione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Sommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Dockery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishakh","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassidy","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Boehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Countryman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malembe","family":"Ebama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"10127","key":"14811_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300. https:\/\/doi.org\/10.1016\/S0140-6736(17)33293-2.","journal-title":"Lancet"},{"key":"14811_CR2","unstructured":"World Health Organization. Influenza (seasonal) 2025 Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"14811_CR3","unstructured":"World Health Organization. Immunization Agenda, 2030: a global Strategy to leave No one behind 2020 Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/ia2030."},{"key":"14811_CR4","unstructured":"World Health Organization. Global Influenza Strategy 2019-2030. 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241515320."},{"issue":"25","key":"14811_CR5","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1016\/j.vaccine.2021.04.043","volume":"39","author":"AM Kraigsley","year":"2021","unstructured":"Kraigsley AM, Moore KA, Bolster A, Peters M, Richardson D, Arpey M, et al. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: a global survey. Vaccine. 2021;39(25):3419\u201327. https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.043.","journal-title":"Vaccine"},{"issue":"2","key":"14811_CR6","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project. J Global Health. 2019;9(2):020421. https:\/\/doi.org\/10.7189\/jogh.09.020421.","journal-title":"J Global Health"},{"key":"14811_CR7","unstructured":"World Health Organization. Pandemic influenza: a threat that all countries need to prepare for Available from: https:\/\/www.who.int\/europe\/emergencies\/emergency-cycle\/prepare\/pandemic-influenza."},{"key":"14811_CR8","unstructured":"U.S. Centers for Disease Control and Prevention. H5 bird flu: current situation 2025 Available from: https:\/\/www.cdc.gov\/bird-flu\/situation-summary\/index.html."},{"key":"14811_CR9","unstructured":"World Health Organization. Vaccines against influenza: WHO position paper -. 2022 Available from: May 2022. https:\/\/www.who.int\/publications\/i\/item\/who-wer9719."},{"key":"14811_CR10","unstructured":"World Health Organization. Prevention and control of influenza pandemics and annual epidemics 2003 Available from: https:\/\/iris.who.int\/handle\/10665\/78320."},{"issue":"4","key":"14811_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","volume":"36","author":"P Jorgensen","year":"2018","unstructured":"Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015. Vaccine. 2018;36(4):442\u201352. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.019.","journal-title":"Vaccine"},{"key":"14811_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijid.2022.10.038","volume":"125","author":"C Chen","year":"2022","unstructured":"Chen C, Liu X, Yan D, Zhou Y, Ding C, Chen L, et al. Global influenza vaccination rates and factors associated with influenza vaccination. Int J Infect Dis. 2022;125:153\u201363. https:\/\/doi.org\/10.1016\/j.ijid.2022.10.038.","journal-title":"Int J Infect Dis"},{"issue":"26","key":"14811_CR13","doi-asserted-by":"publisher","first-page":"126274","DOI":"10.1016\/j.vaccine.2024.126274","volume":"42","author":"S Goldin","year":"2024","unstructured":"Goldin S, Brooks D, Jorgensen P, Wijesinghe P, Cho H, Attia R, et al. Seasonal influenza vaccination: a global review of national policies in 194 WHO member states in 2022. Vaccine. 2024;42(26):126274. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126274.","journal-title":"Vaccine"},{"key":"14811_CR14","unstructured":"World Health Organization. Global market study seasonal influenza vaccine 2024 Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/mi4a\/who_mi4a_global_market_study_seasonal_influenza_vaccine.pdf."},{"issue":"1","key":"14811_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.vaccine.2018.11.048","volume":"37","author":"ML McMorrow","year":"2019","unstructured":"McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Ramkrishna W, Azziz-Baumgartner E, et al. Prioritization of risk groups for influenza vaccination in resource limited settings \u2013 a case study from South Africa. Vaccine. 2019;37(1):25\u201333. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.048.","journal-title":"Vaccine"},{"key":"14811_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2020-9-5","volume":"9","author":"G Kassianos","year":"2021","unstructured":"Kassianos G, Banerjee A, Baron-Papillon F, Hampson AW, McElhaney JE, McGeer A, et al. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. DIC. 2021;9:1\u201313. https:\/\/doi.org\/10.7573\/dic.2020-9-5.","journal-title":"DIC"},{"key":"14811_CR17","unstructured":"World Bank Group. The World Bank in middle income countries 2025 Available from: https:\/\/www.worldbank.org\/en\/country\/mic\/overview#:%7E:text=The%20World%20Bank%20in%20Middle,major%20engines%20of%20global%20growth."},{"issue":"45","key":"14811_CR18","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1016\/j.vaccine.2023.09.027","volume":"41","author":"S Ozawa","year":"2023","unstructured":"Ozawa S, Schuh HB, Nakamura T, Yemeke TT, Lee Y-FA, MacDonald NE. How to increase and maintain high immunization coverage: vaccination demand resilience (VDR) framework. Vaccine. 2023;41(45):6710\u201318. https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.027.","journal-title":"Vaccine"},{"key":"14811_CR19","doi-asserted-by":"publisher","unstructured":"Baxter L, Slater R, Hermany L, Bhatti A, Eiden AL, Mitrovich R, et al. Identifying characteristics that enable resilient immunisation programmes: a scoping review. BMJ Open. 2024;14(5):e072794. https:\/\/doi.org\/10.1136\/bmjopen-2023-072794.","DOI":"10.1136\/bmjopen-2023-072794"},{"issue":"5","key":"14811_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/08404704211028857","volume":"34","author":"SL Sibbald","year":"2021","unstructured":"Sibbald SL, Paciocco S, Fournie M, Van Asseldonk R, Scurr T. Continuing to enhance the quality of case study methodology in health services research. Healthc Manage Forum. 2021;34(5):291\u201396. https:\/\/doi.org\/10.1177\/08404704211028857.","journal-title":"Healthc Manage Forum"},{"key":"14811_CR21","unstructured":"Harrison H, Birks M, Franklin R, Mills J. Case study research: foundations and methodological orientations. Forum Qualitative Sozialforschung\/Forum: Qualitative Soc Res. 2017;18(1)."},{"key":"14811_CR22","volume-title":"Qualitative research: a guide to design and implementation","author":"EJM Tisdell","year":"2025","unstructured":"Tisdell EJM, Sharan B, Stuckey-Peyrot HL. Qualitative research: a guide to design and implementation. San Francisco, CA: Jossey-Bass; 2025."},{"issue":"1","key":"14811_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. https:\/\/doi.org\/10.1186\/1471-2288-13-117.","journal-title":"BMC Med Res Methodol"},{"key":"14811_CR24","unstructured":"Our World in Data. Coronavirus (COVID-19) vaccinations 2022 Available from: https:\/\/ourworldindata.org\/covid-vaccinations."},{"issue":"5","key":"14811_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.vaccine.2014.10.029","volume":"33","author":"JT Owusu","year":"2015","unstructured":"Owusu JT, Prapasiri P, Ditsungnoen D, Leetongin G, Yoocharoen P, Rattanayot J, et al. Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010\u20132012. Vaccine. 2015;33(5):742\u201347. https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.029.","journal-title":"Vaccine"},{"key":"14811_CR26","doi-asserted-by":"publisher","unstructured":"Muangchana C, Thamapornpilas P, Karnkawinpong O. Immunization policy development in Thailand: the role of the advisory committee on immunization practice. Vaccine. 2010;28:A104\u201309. https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.043.","DOI":"10.1016\/j.vaccine.2010.02.043"},{"key":"14811_CR27","unstructured":"World Health Organization. Global influenza surveillance and response system (GISRS) Available from: https:\/\/www.who.int\/initiatives\/global-influenza-surveillance-and-response-system."},{"key":"14811_CR28","doi-asserted-by":"publisher","unstructured":"Budgell E, Cohen AL, McAnerney J, Walaza S, Madhi SA, Blumberg L, et al. Evaluation of two influenza surveillance systems in South Africa. PLoS One. 2015;10(3):e0120226. https:\/\/doi.org\/10.1371\/journal.pone.0120226.","DOI":"10.1371\/journal.pone.0120226"},{"issue":"4","key":"14811_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1750-2659.2011.00302.x","volume":"6","author":"M Chittaganpitch","year":"2012","unstructured":"Chittaganpitch M, Supawat K, Olsen SJ, Waicharoen S, Patthamadilok S, Yingyong T, et al. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004\u20132010. Influenza Resp Viruses. 2012;6(4):276\u201383. https:\/\/doi.org\/10.1111\/j.1750-2659.2011.00302.x.","journal-title":"Influenza Resp Viruses"},{"key":"14811_CR30","unstructured":"Ministry of Public Health. Thai National Influenza Center Available from: https:\/\/thainihnic.org\/influenza\/main.php?option=about_us%26sub_option=role."},{"issue":"5","key":"14811_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/irv.12663","volume":"13","author":"D Chavez","year":"2019","unstructured":"Chavez D, Gonzales-Armayo V, Mendoza E, Palekar R, Rivera R, Rodriguez A, et al. Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data\u2014La Paz, Bolivia. 2012\u20132017. Influenza Resp Viruses. 2019;13(5):477\u201383. https:\/\/doi.org\/10.1111\/irv.12663.","journal-title":"Influenza Resp Viruses"},{"key":"14811_CR32","unstructured":"World Health Organization. Influenza surveillance country, territory and area profiles 2019, 2021 Available from: https:\/\/www.who.int\/europe\/publications\/i\/item\/WHO-EURO-2019-3621-43380-60857."},{"key":"14811_CR33","doi-asserted-by":"publisher","unstructured":"Mash R, Williams B, Stapar D, Hendricks G, Steyn H, Schoevers J, et al. Retention of medical officers in district health services, South Africa: a descriptive survey. BJGP Open. 2022;6(4):BJGPO.2022.0047. https:\/\/doi.org\/10.3399\/BJGPO.2022.0047.","DOI":"10.3399\/BJGPO.2022.0047"},{"key":"14811_CR34","unstructured":"World Health Organization. Flutool Plus. 2020 Available from: https:\/\/www.who.int\/publications\/i\/item\/flutool-plus."},{"key":"14811_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijid.2018.11.326","volume":"79","author":"A Simaku","year":"2019","unstructured":"Simaku A, Preza I, Nelaj E, Sulo J, Bino S. Knowledge, attitudes, and practice regarding influenza vaccination in pregnant women in Albania. Int J Infect Dis. 2019;79:133\u201334. https:\/\/doi.org\/10.1016\/j.ijid.2018.11.326.","journal-title":"Int J Infect Dis"},{"key":"14811_CR36","unstructured":"Instituto Butantan. Available from: https:\/\/butantan.gov.br\/."},{"key":"14811_CR37","unstructured":"World Health Organization. Prequalified Vaccines. 2025 Available from: https:\/\/extranet.who.int\/prequal\/vaccines\/prequalified-vaccines."},{"key":"14811_CR38","unstructured":"World Health Organization. Key elements for the sustainable production of influenza vaccine in Brazil in the framework of the global Action Plan for influenza vaccines 2016 Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/254183\/WHO-HIS-TTi-17.1-eng.pdf."},{"issue":"32","key":"14811_CR39","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1016\/j.vaccine.2012.05.007","volume":"30","author":"CMAS Domingues","year":"2012","unstructured":"Domingues CMAS, de Oliveira WK. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010. Vaccine. 2012;30(32):4744\u201351. https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.007.","journal-title":"Vaccine"},{"issue":"1","key":"14811_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12960-023-00853-1","volume":"21","author":"L D\u2019Ambruoso","year":"2023","unstructured":"D\u2019Ambruoso L, Abruquah NA, Mabetha D, van der Merwe M, Goosen G, Sigudla J, et al. Expanding community health worker decision space: learning from a participatory Action research training intervention in a rural South African district. Hum Resour Health. 2023;21(1):66. https:\/\/doi.org\/10.1186\/s12960-023-00853-1.","journal-title":"Hum Resour Health"},{"key":"14811_CR41","doi-asserted-by":"publisher","unstructured":"Anstey Watkins J, Griffiths F, Goudge J. Community health workers\u2019 efforts to build health system trust in marginalised communities: a qualitative study from South Africa. BMJ Open. 2021;11(5):e044065. https:\/\/doi.org\/10.1136\/bmjopen-2020-044065.","DOI":"10.1136\/bmjopen-2020-044065"},{"issue":"7","key":"14811_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/vaccines9070713","volume":"9","author":"C Lin","year":"2021","unstructured":"Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers\u2019 vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Nato Adv Sci Inst Se. 2021;9(7):713. https:\/\/doi.org\/10.3390\/vaccines9070713.","journal-title":"Nato Adv Sci Inst Se"},{"key":"14811_CR43","doi-asserted-by":"publisher","unstructured":"Praphasiri P, Ditsungneon D, Greenbaum A, Dawood FS, Yoocharoen P, Stone DM, et al. Do Thai physicians recommend seasonal influenza vaccines to pregnant women? A cross-sectional survey of physicians\u2019 perspectives and practices in Thailand. PLoS One. 2017;12(1):e0169221. https:\/\/doi.org\/10.1371\/journal.pone.0169221.","DOI":"10.1371\/journal.pone.0169221"},{"key":"14811_CR44","doi-asserted-by":"crossref","unstructured":"Minakawa MM, Fraz\u00e3o P. The trajectory of Brazilian immunization program between 1980 and 2018: from the virtuous cycle to the vaccine coverage decline. Vaccines (Basel). 2023;11(7).","DOI":"10.3390\/vaccines11071189"},{"key":"14811_CR45","unstructured":"Instituti i Sh\u00ebndetit Publik. Java e Nd\u00ebrgjegj\u00ebsimit ndaj Gripit 2018 Available from: https:\/\/www.ishp.gov.al\/java-e-ndergjegjesimit-ndaj-gripit\/."},{"key":"14811_CR46","unstructured":"International Pharmaceutical Federation (FIP). Strategies for expanding pharmacy based vaccination: a policy toolkit for pharmacists 2025 Available from: https:\/\/www.fip.org\/file\/6439."},{"key":"14811_CR47","unstructured":"Pan American Health Organization. Behavioral science: vaccine demand and confidence Available from: https:\/\/www.paho.org\/en\/topics\/immunization\/immunization-toolkit\/behavioral-science-vaccine-demand-and-confidence."},{"key":"14811_CR48","unstructured":"World Health Organization. Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake 2022 Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240049680."},{"key":"14811_CR49","unstructured":"Berger M. The weird and wacky mascots promoting coronavirus vaccines around the world. The Washington Post. 2021."},{"key":"14811_CR50","doi-asserted-by":"publisher","unstructured":"Rajatanavin N, Tuangratananon T, Suphanchaimat R, Tangcharoensathien V. Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Glob Health. 2021;6(7):e006178. https:\/\/doi.org\/10.1136\/bmjgh-2021-006178.","DOI":"10.1136\/bmjgh-2021-006178"},{"key":"14811_CR51","unstructured":"World Health Organization. Thailand\u2019s 1 million village health volunteers - \u201cunsung heroes\u201d - are helping guard communities nationwide from COVID-19 2020 Available from: https:\/\/www.who.int\/thailand\/news\/feature-stories\/detail\/thailands-1-million-village-health-volunteers-unsung-heroes-are-helping-guard-communities-nationwide-from-covid-19."},{"issue":"2","key":"14811_CR52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.18999\/nagjms.86.2.252","volume":"86","author":"R Sairuk","year":"2024","unstructured":"Sairuk R, Nishino K, Inthaphatha S, Hamajima N, Yamamoto E. Comparison of the influenza vaccination coverage among high-risk people between the online registration system and walk-in service system in Bangkok, Thailand. Nagoya J Med Sci. 2024;86(2):252\u201361. https:\/\/doi.org\/10.18999\/nagjms.86.2.252.","journal-title":"Nagoya J Med Sci"},{"issue":"1","key":"14811_CR53","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1186\/s12913-021-06962-8","volume":"21","author":"K Bishop","year":"2021","unstructured":"Bishop K, McMorrow M, Meiring S, Walaza S, Rossi L, Mhlanga S, et al. An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 \u2013 2018. BMC Health Serv Res. 2021;21(1):941. https:\/\/doi.org\/10.1186\/s12913-021-06962-8.","journal-title":"BMC Health Serv Res"},{"key":"14811_CR54","unstructured":"World Health Organization. Influenza vaccination coverage Available from: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/influenza-vaccination-coverage."},{"key":"14811_CR55","unstructured":"World Health Organization. Immunization analysis and insights Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/immunization-analysis-and-insights\/surveillance?utm_source=chatgpt.com."},{"key":"14811_CR56","unstructured":"The Partnership for International Vaccine Initiatives. SECID countries form a collaborative network to support vaccination in Southeast European region 2024 Available from: https:\/\/pivipartners.org\/secid-countries-form-a-collaborative-network-to-support-vaccination-in-southeast-european-region\/."},{"key":"14811_CR57","unstructured":"Connecting organisations for regional disease surveillance (CORDS). SECID Available from: https:\/\/www.cordsnetwork.org\/networks\/secid\/."},{"issue":"4","key":"14811_CR58","doi-asserted-by":"publisher","first-page":"125534","DOI":"10.1016\/j.vaccine.2023.12.044","volume":"42","author":"AM Volkmann","year":"2024","unstructured":"Volkmann AM, Goldin S, McMurren B, Gapare C, Anne Pratt B, Frost L, et al. Leveraging seasonal influenza health worker vaccination programmes for COVID-19 vaccine Introduction: a global qualitative analysis. Vaccine. 2024;42(4):125534. https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.044.","journal-title":"Vaccine"},{"key":"14811_CR59","unstructured":"World Health Organization. Influenza health worker vaccination programmes: platforms for pandemic preparedness 2024 Available from: https:\/\/www.who.int\/news\/item\/30-03-2024-influenza-health-worker-vaccination-programmes-platforms-for-pandemic-preparedness."},{"issue":"7902","key":"14811_CR60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603(7902):679\u201386. https:\/\/doi.org\/10.1038\/s41586-022-04411-y.","journal-title":"Nature"},{"issue":"12","key":"14811_CR61","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/vaccines12121415","volume":"12","author":"F Nogareda","year":"2024","unstructured":"Nogareda F, Ghiselli M, Velandia-Gonz\u00e1lez M, de Mucio B, Jara J, Couto P, et al. Seasonal influenza vaccination programs in the Americas: a platform for sustainable life-course immunization and its role for pandemic preparedness and response. Vaccines (Basel). 2024;12(12):1415. https:\/\/doi.org\/10.3390\/vaccines12121415.","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"14811_CR62","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.vaccine.2019.11.025","volume":"38","author":"RM Porter","year":"2020","unstructured":"Porter RM, Goldin S, Lafond KE, Hedman L, Ungkuldee M, Kurzum J, et al. Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic. Vaccine. 2020;38(5):1152\u201359. https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.025.","journal-title":"Vaccine"},{"key":"14811_CR63","doi-asserted-by":"publisher","unstructured":"Tupps C, Curry D, Edwards A, Bazant E, Moen A, Mounts AW, et al. COVID-19 vaccination implementation in six lower- and middle-income countries: successes, challenges, and lessons for pandemic preparedness. PLoS Glob Public Health. 2025;5(5):e0004417. https:\/\/doi.org\/10.1371\/journal.pgph.0004417.","DOI":"10.1371\/journal.pgph.0004417"},{"issue":"4","key":"14811_CR64","doi-asserted-by":"publisher","first-page":"125528","DOI":"10.1016\/j.vaccine.2023.12.038","volume":"42","author":"S Goldin","year":"2024","unstructured":"Goldin S, Moen A, Moss WJ, Nuzzo J. Assessing the relationship between existing childhood, adolescent and adult immunization programmes and national COVID-19 vaccination capacities in 2021. Vaccine. 2024;42(4):125528. https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.038.","journal-title":"Vaccine"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14811-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14811-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:28:23Z","timestamp":1785968903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14811-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14811"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14811-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was conducted as a public health program evaluation and health systems analysis, drawing on publicly available and secondary data sources and structured consultations with professionals engaged in influenza vaccination programs in their institutional or technical roles. In accordance with standard definitions of human subjects research, this activity did not involve the collection of data about identifiable individuals or private information and therefore did not meet the criteria for human subjects research. As such, institutional review board or research ethics committee approval was not required. No personal, sensitive, or identifiable information was collected, recorded, or included in this study. Stakeholder consultations were conducted solely to obtain expert perspectives on programmatic and policy considerations rather than personal experiences. Participation in consultations was voluntary. Verbal informed consent was obtained from all participants prior to each consultation using a standardized script. Participants were informed of the purpose of the activity, how the information would be used, and their rights to decline participation, withdraw at any time, or refrain from answering specific questions. To ensure confidentiality and data protection, no names or direct identifiers were recorded, and all findings are presented in aggregate, non-attributable form. Notes from consultations were securely stored and accessible only to the study team. The project adhered to established ethical principles, including respect for persons, voluntary participation, minimization of risk, and protection of confidentiality.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.B. has been employed by Pfizer since January 2025, after the completion of his contributions to this study. J.T. was employed by Manatt Health, from February 2023 to June 2025, following his work on the study, during which time he provided consulting services to Regeneron, J&J, Gilead, and Denali. The following authors do not have any competing interests to disclose: A.M., A.T., B.M., C.H., D.C., K.H., M.D., M.E., M.Mal., M.Maz., T.S., V.U., S.K.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1059"}}